Osteomyelitis exposed: Advances in treatment

Osteomyelitis, an increasingly prevalent bone infection, presents a multifaceted clinical challenge due to its diverse causes, complex classification systems, and variable presentations across age groups. The article—since retracted for plagiarism—attempted to provide a comprehensive overview of osteomyelitis classification, diagnosis, and treatment, particularly emphasizing chronic and diabetic foot-related cases. While the Cierny-Mader system remains the preferred surgical staging tool, the Waldvogel system provides broader clinical categorization based on etiology and disease duration. Both frameworks aim to guide treatment decisions by correlating disease severity with host factors.

Diagnostic approaches highlighted include imaging techniques like MRI, CT, and biopsy, with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) aiding initial assessments. Thresholds of ESR ≥60 mm/h and CRP ≥7.9 mg/dL were suggested as potential indicators of bone infection, particularly in diabetic patients. Acute hematogenous osteomyelitis remains common in children, while chronic variants manifest with necrosis and fistulous tracts, especially in immunocompromised or diabetic patients.

Management hinges on tailored antibiotic regimens—often initiated intravenously—alongside surgical debridement in chronic or refractory cases. Emerging treatments include one-stage surgeries utilizing bioactive biomaterials (e.g., BonAlive®, Cerament™ G) and hyperbaric oxygen therapy (HBOT), shown to enhance bone healing and reduce recurrence. However, determining antibiotic duration, delivery method, and long-term outcomes remains contentious in clinical practice.

Despite its retraction for unethical authorship practices, the article reflects real concerns in osteomyelitis management: escalating antibiotic resistance, delayed diagnosis, and inconsistent treatment protocols. Will future osteomyelitis care rely more on individualized risk profiles, innovative biomaterials, or AI-driven diagnostics? The pursuit of clarity in this chronic puzzle continues.